ASCT CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. ASCT Gen Silencer sind erhältlich als ASCT CRISPR/Cas9 Knockout Plasmide und ASCT Double Nickase Plasmide. ASCT CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
ASCT CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
ASCT1 CRISPR/Cas9 KO Plasmid (h) | sc-409194 | h | Gene Knockout | GFP | 0 | ||
ASCT1 HDR Plasmid (h) | sc-409194-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
ASCT1 Double Nickase Plasmid (h) | sc-409194-NIC | h | Gene Knockout | Puromycin | 0 | ||
ASCT1 Double Nickase Plasmid (h2) | sc-409194-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
ASCT1 CRISPR/Cas9 KO Plasmid (m) | sc-424954 | m | Gene Knockout | GFP | 0 | ||
ASCT1 HDR Plasmid (m) | sc-424954-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
ASCT1 Double Nickase Plasmid (m) | sc-424954-NIC | m | Gene Knockout | Puromycin | 0 | ||
ASCT1 Double Nickase Plasmid (m2) | sc-424954-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
ASCT2 CRISPR/Cas9 KO Plasmid (h) | sc-402795 | h | Gene Knockout | GFP | 0 | ||
ASCT2 HDR Plasmid (h) | sc-402795-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
ASCT2 Double Nickase Plasmid (h) | sc-402795-NIC | h | Gene Knockout | Puromycin | 0 | ||
ASCT2 Double Nickase Plasmid (h2) | sc-402795-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
ASCT2 CRISPR/Cas9 KO Plasmid (m) | sc-422987 | m | Gene Knockout | GFP | 0 | ||
ASCT2 HDR Plasmid (m) | sc-422987-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
ASCT2 Double Nickase Plasmid (m) | sc-422987-NIC | m | Gene Knockout | Puromycin | 0 | ||
ASCT2 Double Nickase Plasmid (m2) | sc-422987-NIC-2 | m | Gene Knockout | Puromycin | 0 |
ASCT CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
ASCT1 CRISPR Activation Plasmid (h) | sc-409194-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASCT1 CRISPR Activation Plasmid (h2) | sc-409194-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASCT1 Lentiviral Activation Particles (h) | sc-409194-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASCT1 Lentiviral Activation Particles (h2) | sc-409194-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASCT1 CRISPR Activation Plasmid (m) | sc-424954-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASCT1 CRISPR Activation Plasmid (m2) | sc-424954-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASCT1 Lentiviral Activation Particles (m) | sc-424954-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASCT1 Lentiviral Activation Particles (m2) | sc-424954-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASCT2 CRISPR Activation Plasmid (h) | sc-402795-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASCT2 CRISPR Activation Plasmid (h2) | sc-402795-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASCT2 Lentiviral Activation Particles (h) | sc-402795-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASCT2 Lentiviral Activation Particles (h2) | sc-402795-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASCT2 CRISPR Activation Plasmid (m) | sc-422987-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASCT2 CRISPR Activation Plasmid (m2) | sc-422987-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASCT2 Lentiviral Activation Particles (m) | sc-422987-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASCT2 Lentiviral Activation Particles (m2) | sc-422987-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |